Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

individual

individual is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 13
Pipeline programs 15
News articles 0
Drug details — individual
Class
—
Route
—
Patents
13
Programs
15
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

individual is an FDA-listed pharmaceutical active ingredient.

Key facts

INN individual

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 42-1703 Phase 3 · Aquestive Therapeutics · Epilepsy
  2. APHP200056 Phase 3 · PARItec · Remyelination in Multiple Sclerosis
  3. Individualized Elective Neck Irradiation Phase 3 · Chinese Academy of · Nasopharyngeal Carcinoma
  4. individual lactation counseling and educational material Phase 3 · Hospital Authority · Breastfeeding
  5. DSE-BMP-0001-CIS-MA Phase 1 · Daiichi Sankyo US · No medical condition.
  6. DSE-BMP-0002-CIS-MA Phase 1 · Daiichi Sankyo US · No medical condition
  7. DSE-BMP-0003-CIS-MA Phase 1 · Daiichi Sankyo US · No medical condition.
  8. ION269-CS1 Phase 1 · IONIS PHARMACEUTICALS · Alzheimer’s Disease in Individuals with Down Syndrome

Related patents

Browse patents

  1. US 11850535

    Methods for quantitating individual antibodies from a mixture

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11571636

    Methods for quantitating individual antibodies from a mixture

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11369896

    Methods for quantitating individual antibodies from a mixture

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11020686

    Methods for quantitating individual antibodies from a mixture

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10867702

    Individual and cohort pharmacological phenotype prediction platform

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10553318

    Individual and cohort pharmacological phenotype prediction platform

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10249389

    Individual and cohort pharmacological phenotype prediction platform

    Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7910323

    Methods for identifying the effect of a drug agent on the metabolism of sugars and fats in an individual

    Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 2011062165

    BALANCED INDIVIDUAL DINING PLATE

    Expires Wed Mar 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7662780

    Administering hypocretin to obese individuals

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7651707

    Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome

    Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7504233

    Methods for determining the metabolism of sugars and fats in an individual

    Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 6261567

    Overcoming interference in alphavirus immune individuals

    Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is individual?

individual is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.